Interface Engineering Will Sell, Service Eksigent's HPLCs in S. Korea

Apr 30, 2007

NEW YORK (GenomeWeb News) — Seoul, South Korea-based Interface Engineering will sell and service Eksigent’s NanoLC and ExpressLC high-performance liquid-chromatography systems in Korea, Eksigent said today.

Interface Engineering is a division of Bio-Medical Science Co., a group of Korean distribution and life-science technology companies.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.